The Australian Competition and Consumer Commission has launched a safety review of bouncers, rockers and inclined sleep products for babies after at least 74 infant fatalities were reported in the United States.
A Queensland couple has filed a product liability claim against Samsung seeking almost half a million dollars in damages, after their washing machine allegedly exploded and sparked a fire that burnt their house to the ground.
Slater & Gordon has filed a class action against life sciences giant Bayer over allegedly defective contraceptive implants that caused serious side effects, requiring many patients fitted with the devices to have hysterectomies.
German-based cladding manufacturer 3A Composites has foreshadowed potential cross claims against third party engineers and certifiers in one of two class actions brought over allegedly dangerous combustible cladding used in countless buildings across Australia.
The contractor behind the Ichthys LNG project has won court approval to use documents discovered in its lawsuit against Dutch paint manufacturer AkzoNobel for use in any potential dispute with INPEX, the head company behind the liquid natural gas project.
Medical device manufacturer American Medical Systems has reasserted that it cannot face claims under Australian consumer laws over its allegedly defective vaginal mesh products because it only supplied the products to a US subsidiary.
The judge overseeing several class actions over the alleged use of toxic foam at government military bases has appointed a special counsel to hear the Commonwealth’s claims that it should be exempt for producing certain documents due to public interest immunity and legal professional privilege.
A second combustible cladding class action has been launched, this time against Fairview Architectural, the Australian manufacturer of Vitrabond polyethylene cladding, which it claims has been used at major Australian airports, entertainment facilities and government buildings.
Group members in a class action against Johnson & Johnson unit DePuy International over allegedly defective hip implants are on track to receive 100 per cent of their claims as the $250 million settlement continues to be distributed, a court has heard.
The law firm running the first Australian cancer case against RoundUp weedkiller producer Monsanto has questioned whether victims would get the ātrue valueā of their claims if a class action was launched.